Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review.
Milunović V, Hude I, Rinčić G, Galušić D, Grubešić A, Martinović M, Popović N, Divošević S, Brčić K, Međugorac M, Kužat L, Strahija D, Mrđenović S, Mandac Smoljanović I, Radić-Krišto D, Gašparov S, Aurer I, Ostojić Kolonić S. Milunović V, et al. Among authors: aurer i. Biomedicines. 2022 Nov 14;10(11):2917. doi: 10.3390/biomedicines10112917. Biomedicines. 2022. PMID: 36428485 Free PMC article. Review.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases.
Galusic D, Basic-Kinda S, Pijuk A, Milunovic V, Dreta B, Franjic N, Coha B, Sincic-Petricevic J, Gacina P, Pejsa V, Lucijanic M, Aurer I. Galusic D, et al. Among authors: aurer i. Hemasphere. 2022 Nov 15;6(12):e807. doi: 10.1097/HS9.0000000000000807. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36407092 Free PMC article.
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.
Sertić Z, Lucijanić M, Bašić-Kinda S, Serventi Seiwerth R, Periša V, Sertić D, Coha B, Pulanić D, Perić Z, Desnica L, Mikulić M, Vodanović M, Radman-Livaja I, Šegulja D, Rogić D, Valković T, Aurer I, Duraković N. Sertić Z, et al. Among authors: aurer i. Biomedicines. 2022 Nov 11;10(11):2892. doi: 10.3390/biomedicines10112892. Biomedicines. 2022. PMID: 36428459 Free PMC article.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).
Mitrovic Z, Dujmovic D, Jaksic O, Kinda SB, Gacina P, Perisa V, Prka Z, Dreta B, Galusic D, Holik H, Pejsa V, Aurer I. Mitrovic Z, et al. Among authors: aurer i. Eur J Haematol. 2023 Jun;110(6):725-731. doi: 10.1111/ejh.13957. Epub 2023 Apr 2. Eur J Haematol. 2023. PMID: 36941738
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
Hude Dragičević I, Bašić-Kinda S, Markotić H, Morić-Perić M, Dujmović D, Radman I, Dreta B, Dotlić S, Ilić I, Galunić Bilić L, Dobrenić M, Kralik M, Aurer I. Hude Dragičević I, et al. Among authors: aurer i. Medicina (Kaunas). 2024 Mar 2;60(3):430. doi: 10.3390/medicina60030430. Medicina (Kaunas). 2024. PMID: 38541156 Free PMC article.
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Fiaccadori V, Neven A, Fortpied C, Aurer I, Andre M, Federico M, Counsell N, Phillips EH, Clifton-Hadley L, Barrington SF, Illidge T, Radford J, Raemaekers JMM. Fiaccadori V, et al. Among authors: aurer i. Br J Haematol. 2023 Mar;200(6):731-739. doi: 10.1111/bjh.18594. Epub 2022 Dec 21. Br J Haematol. 2023. PMID: 36541117
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.
Aurer I, Jakšić O, Bašić-Kinda S, Mrđenović S, Ostojić-Kolonić S, Lozić D, Holik H, Novaković-Coha S, Berneš P, Krečak I, Morić-Perić M, Narančić M, Mitrović Z, Valković T. Aurer I, et al. Biomedicines. 2024 Jan 31;12(2):331. doi: 10.3390/biomedicines12020331. Biomedicines. 2024. PMID: 38397933 Free PMC article.
105 results